Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies

R Akbar, H Bashour, P Rawat, PA Robert, E Smorodina… - MAbs, 2022 - Taylor & Francis
Although the therapeutic efficacy and commercial success of monoclonal antibodies (mAbs)
are tremendous, the design and discovery of new candidates remain a time and cost …

Subcutaneous delivery of monoclonal antibodies: how do we get there?

M Viola, J Sequeira, R Seiça, F Veiga, J Serra… - Journal of controlled …, 2018 - Elsevier
The convenience of subcutaneous (SC) administration and the increasing interest in
monoclonal antibody (mAb)-based therapies for chronic diseases, hint their potential for SC …

The role of Raman spectroscopy in biopharmaceuticals from development to manufacturing

KA Esmonde-White, M Cuellar, IR Lewis - Analytical and Bioanalytical …, 2022 - Springer
Biopharmaceuticals have revolutionized the field of medicine in the types of active
ingredient molecules and treatable indications. Adoption of Quality by Design and Process …

Instability of therapeutic proteins—An overview of stresses, stabilization mechanisms and analytical techniques involved in Lyophilized proteins

A Butreddy, KY Janga, S Ajjarapu, S Sarabu… - International journal of …, 2021 - Elsevier
Solid-state is the preferred choice for storage of protein therapeutics to improve stability and
preserve the biological activity by decreasing the physical and chemical degradation …

Overview of antibody drug delivery

S Awwad, U Angkawinitwong - Pharmaceutics, 2018 - mdpi.com
Monoclonal antibodies (mAbs) are one of the most important classes of therapeutic proteins,
which are used to treat a wide number of diseases (eg, oncology, inflammation and …

Molecular basis of high viscosity in concentrated antibody solutions: Strategies for high concentration drug product development

DS Tomar, S Kumar, SK Singh, S Goswami, L Li - MAbs, 2016 - Taylor & Francis
Effective translation of breakthrough discoveries into innovative products in the clinic
requires proactive mitigation or elimination of several drug development challenges. These …

Molecular rationale for SARS-CoV-2 spike circulating mutations able to escape bamlanivimab and etesevimab monoclonal antibodies

E Laurini, D Marson, S Aulic, A Fermeglia, S Pricl - Scientific Reports, 2021 - nature.com
The purpose of this work is to provide an in silico molecular rationale of the role eventually
played by currently circulating mutations in the receptor binding domain of the SARS-CoV-2 …

A review of tangential flow filtration: process development and applications in the pharmaceutical industry

P Agrawal, K Wilkstein, E Guinn… - … Process Research & …, 2023 - ACS Publications
Tangential flow filtration is an efficient membrane separation technology utilized across a
wide range of industries for separation and purification applications. The requirement of …

Antibody fragments as potential biopharmaceuticals for cancer therapy: success and limitations

RV Kholodenko, DV Kalinovsky… - Current Medicinal …, 2019 - ingentaconnect.com
Monoclonal antibodies (mAbs) are an important class of therapeutic agents approved for the
therapy of many types of malignancies. However, in certain cases applications of …

FSH-blocking therapeutic for osteoporosis

S Gera, TC Kuo, AA Gumerova, F Korkmaz, D Sant… - Elife, 2022 - elifesciences.org
Pharmacological and genetic studies over the past decade have established the follicle-
stimulating hormone (FSH) as an actionable target for diseases affecting millions, namely …